Health Law & Business News

Regeneron Covid Drug to Roll Out in 30,000-Dose Shipment (1)

Nov. 23, 2020, 8:34 PM

Thirty thousand doses of Regeneron Pharmaceuticals Inc.’s antibody cocktail will be shipped Tuesday, after the experimental coronavirus treatment got an emergency authorization from U.S. regulators.

Health and Human Services Secretary Alex Azar detailed plans to distribute the therapy at a news conference on Monday. The drug, called REGN-COV2, received clearance from the U.S. Food and Drug Administration for treatment of mild to moderate Covid-19 in adults and some children of at least 12 years of age.

Earlier this year, Regeneron agreed to a $450 million supply deal with Operation Warp Speed, the U.S. program to accelerate the development of...

To read the full article log in. To learn more about a subscription click here.